965.83MUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
8.11
PEG Ratio
-
Book Value
4.55
Dividend Share
0.33
Dividend Yield
51.55%
Earnings Share
0.08
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,376,656,000
Gross Profit TTM
991,964,032
EBITDA
568,065,024
Profit Margin
35.89%
Return On Assets TTM
8.22%
Return On Equity TTM
13.83%
Revenue Per Share TTM
1.645
Qtly Revenue Growth YOY
-18.20%
Diluted Eps TTM
0.08
Qtly Earnings Growth YOY
-17.40%
Trailing PE
8.11
Forward PE
0
Price Sales TTM
0.7016
Price Book MRQ
1.0962
Enterprise Value Revenue
3
Enterprise Value EBITDA
6
138.65
4.10%153.47
0.80%13.80
0.51%39.37
0.00%32.13
0.00%27.57
-0.97%15.04
-0.56%5.03
-0.40%131.87
-0.04%14.70
-0.03%